LMP-420, a small-molecule inhibitor of TNF-alpha, reduces replication of HIV-1 and <it>Mycobacterium tuberculosis </it>in human cells
<p>Abstract</p> <p>Background</p> <p>Co-infections of human immunodeficiency virus (HIV) and <it>Mycobacterium tuberculosis </it>(<it>M. Tb</it>) are steadily increasing and represent a major health crisis in many developing countries. Both patho...
Main Authors: | Tangsinmankong Nutthapong, Stenger Steffen, Beigier-Pompadre Macarena, Kamchaisatian Wasu, Day Noorbibi K, Haraguchi Soichi, Sleasman John W, Pizzo Salvatore V, Cianciolo George J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-03-01
|
Series: | AIDS Research and Therapy |
Online Access: | http://www.aidsrestherapy.com/content/3/1/8 |
Similar Items
-
Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription
by: Cianciolo George, et al.
Published: (2008-03-01) -
LMP-420, a Small Molecular Inhibitor of TNF-α, Prolongs Islet Allograft Survival by Induction of Suppressor of Cytokine Signaling-1: Synergistic Effect with Cyclosporin-A
by: Nataraju Angaswamy, et al.
Published: (2012-06-01) -
Evaluation of LMP-420: A Novel, Nontoxic Drug with Anti-Inflammatory Properties and Therapeutic Potential for CLL
by: Mowery, Yvonne Marie
Published: (2012) -
Congestion management and LMP
by: Liu, Yun
Published: (2010) -
The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis
by: Timothy French, et al.
Published: (2021-04-01)